 HAYWARD, Calif., Sept. 10, 2021 PRNewswire -- AcelRx Pharmaceuticals, Inc. Nasdaq: ACRX, AcelRx, a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that management will be providing an overview of the business and company updates at the H.C. 